EGFR and colorectal carcinoma: Moreover, resistance to anti-EGFR drugs accompanied by high AXL expression was demonstrated in three-dimensional CRC cell cultures derived from an AXL-positive, RAS wild-type patient after anti-EGFR treatment (9).